<bill session="110" type="hc" number="192" updated="2009-01-08T15:51:23-05:00">
	<status><introduced date="1185336000" datetime="2007-07-25"/></status>

	<introduced date="1185336000" datetime="2007-07-25"/>
	<titles>
		<title type="official" as="introduced">Expressing the sense of Congress regarding the need for further study of the neurological disorder dysnia.</title>
	</titles>
	<sponsor id="400093"/>
	<cosponsors>

	</cosponsors>
	<actions>
		<action date="1185336000" datetime="2007-07-25"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action date="1185336000" datetime="2007-07-25"><text>Referred to the Subcommittee on Health.</text></action>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>

	</subjects>
	<amendments>

	</amendments>
	<summary>
	7/25/2007--Introduced.<br/>Urges the Director of the National Institutes of Health (NIH) to take a leadership role in the fight against the neurological disorder dystonia. Calls for: (1) increased funding for basic biomedical research for dystonia and other neurological disorders through NIH; (2) additional research to identify an accurate diagnostic test for dystonia and an epidemiological study to determine the frequency of the disease; (3) improved patient access to safe and effective dystonia therapies; and (4) increased public awareness and professional education regarding dystonia through partnerships between the government and patient advocacy organizations.<br/>
	</summary>
</bill>
